BAYER AG
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Public
- Established
- 1863-08-01
- Employees
- 99.7K
- Market Cap
- $30.1B
- Website
- http://www.bayer.com
Retrospective Data Analysis of Patients Treated for Macular Edema Due to Central Retinal Vein Occlusion
- First Posted Date
- 2016-01-05
- Last Posted Date
- 2018-09-06
- Lead Sponsor
- Bayer
- Target Recruit Count
- 126
- Registration Number
- NCT02645747
Phase Ib Study of Anetumab Ravtansine in Combination With Pemetrexed and Cisplatin in Mesothelin-expressing Solid Tumors
Phase 1
Completed
- Conditions
- Medical Oncology
- Interventions
- First Posted Date
- 2015-12-24
- Last Posted Date
- 2019-11-07
- Lead Sponsor
- Bayer
- Target Recruit Count
- 36
- Registration Number
- NCT02639091
A Study to Test the Safety and Efficacy of the Drug Larotrectinib for the Treatment of Tumors With NTRK-fusion in Children
Phase 1
Active, not recruiting
- Conditions
- Solid Tumors Harboring NTRK Fusion
- Interventions
- First Posted Date
- 2015-12-22
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Bayer
- Target Recruit Count
- 154
- Registration Number
- NCT02637687
- Locations
- 🇩🇰
Rigshospitalet - Børn og Unge, Copenhagen, Denmark
🇫🇷Institut Curie - Ulm - Paris, PARIS cedex 5, France
🇳🇱Prinses Maxima Centrum, Utrecht, Netherlands
A Study Investigating Routine Practice of Chronic Thromboembolic Pulmonary Hypertension Management in EMEA Countries
Completed
- Conditions
- Hypertension, Pulmonary
- Interventions
- Other: Standard of care
- First Posted Date
- 2015-12-22
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Bayer
- Target Recruit Count
- 231
- Registration Number
- NCT02637050
Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)
Phase 3
Terminated
- Conditions
- Lymphoma, Non-Hodgkin
- Interventions
- First Posted Date
- 2015-12-10
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- Bayer
- Target Recruit Count
- 551
- Registration Number
- NCT02626455
- Locations
- 🇺🇸
Memorial Sloan Kettering Cancer Center- Bergen, New York, New York, United States
🇧🇷Hospital de Clinicas de Porto Alegre | Clinical Research Center - Surgery Research Center, Porto Alegre, Rio Grande Do Sul, Brazil
🇧🇷Irmandade da Santa Casa de Misericordia de Porto Alegre | Hospital Sao Francisco - Centro Medico Pesquisa Clinica Cardiologia, Porto Alegre, Rio Grande Do Sul, Brazil
A Study to Learn How Well Nifurtimox Works and How Safe it is in Children Aged 0 to 17 Years With Chagas' Disease, an Inflammatory, Infectious Disease Caused by the Parasite Trypanosoma Cruzi
Phase 3
Completed
- Conditions
- Chagas Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2015-12-09
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Bayer
- Target Recruit Count
- 330
- Registration Number
- NCT02625974
Vericiguat Drug-drug Interaction With Nitroglycerin in Stable Coronary Artery Disease Patients
Phase 1
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2021-12-29
- Lead Sponsor
- Bayer
- Target Recruit Count
- 36
- Registration Number
- NCT02617550
To Investigate Efficacy of YAZ in the Treatment of Dysmenorrhea
Phase 3
Withdrawn
- Conditions
- Dysmenorrhea
- Interventions
- Drug: PlaceboDrug: EE20/DRSP(YAZ,BAY86-5300)
- First Posted Date
- 2015-12-01
- Last Posted Date
- 2016-02-17
- Lead Sponsor
- Bayer
- Registration Number
- NCT02617537
HCC Patient Preferences in Japan
Completed
- Conditions
- Hepatocellular Cancer
- Interventions
- Drug: Hepatocellular Cancer (HCC) treatments including oral anti-cancer therapy [Nexavar (Sorafenib, BAY43-9006)]
- First Posted Date
- 2015-11-30
- Last Posted Date
- 2017-09-27
- Lead Sponsor
- Bayer
- Target Recruit Count
- 120
- Registration Number
- NCT02616692
Curing Atopic Dermatits in Children With a Commerical Medical Device and Maintaining Healthy Skin by Using a New Cosmetic Product
Not Applicable
Completed
- Conditions
- Dermatitis, Atopic
- Interventions
- Other: Stelatopia (cosmetic comparator)
- First Posted Date
- 2015-11-26
- Last Posted Date
- 2017-09-15
- Lead Sponsor
- Bayer
- Target Recruit Count
- 136
- Registration Number
- NCT02615561
© Copyright 2025. All Rights Reserved by MedPath